The next president should use every tool to rebuild America’s productivity, industrial base and middle class. And they should ignore the conventional economic textbook view that predicts calamity if those tools are used, especially because these predictions never come true.
U.S. Trade Representative Katherine Tai took to the Financial Times this week to re-state her position, and President Biden’s, that from now on, global trade has to benefit the common good.
CPA has championed the need for the United States to free itself from the Literally America Last shackles of WTO tariff commitments. Most are unaware that every WTO Member, including the United States, has pledged maximum tariff rates applicable to every other WTO member. Under the WTO system, there’s no single maximum rate, but rather…
When drugs are pulled from pharmacy shelves, it’s somewhat of a well-kept secret that it is the pharmaceutical company that voluntarily warns buyers of the potential harm from the defect.
The U.S. Senate Finance Subcommittee for International Trade, Customs, and Global Competitiveness took a one-sided view on the de minimis exemption in a hearing on Tuesday, rejecting anything but technocratic changes to the global duty-free rule for small packages priced under $800.
Treasury Secretary Janet Yellen was in Europe this week on a charm offensive from Washington, trying to convince leaders there to join forces in going after China on trade.
A new trade policy isn’t just emerging; it’s emerged. Six years after former President Donald Trump and his chief trade diplomat Robert Lighthizer imposed tariffs on nearly $400 billion worth of imported goods from China, President Biden has done the same.
In six short years, there is now a strong, bipartisan consensus that trade with China is a serious issue that is harming our nation, workers, and producers.
Generic drug exporter Zydus Lifesciences received poor marks again in April following a Food and Drug Administration inspection of its lab in Vadodara, a city in Gujarat state on India’s western coast.
The Veterans Health Administration (VHA) banned the use of plastic syringes made in China on April 23 due to safety concerns, ahead of a warning letter dated April 24 to Ohio-based importer Cardinal Health by the Food and Drug Administration.
